A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti, G Capasso, A Cervo… - Journal of …, 2015 - Springer
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca 2+ efflux from the inositol-1, 4, 5-triphosphate …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is able to
stimulate autophagy, and to reduce Ca (2+) efflux from the inositol-1, 4, 5-triphosphate …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2.

F Sacca, G Puorro, A Brunetti, G Capasso… - JOURNAL OF …, 2015 - iris.unina.it
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is able to
stimulate autophagy, and to reduce Ca (2+) efflux from the inositol-1, 4, 5-triphosphate …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti, G Capasso… - Journal of …, 2015 - search.proquest.com
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca^ sup 2+^ efflux from the inositol-1, 4, 5 …

[PDF][PDF] A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Sacca, G Puorro, A Brunetti, G Capasso, A Cervo… - 2014 - academia.edu
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca2? efflux from the inositol-1, 4, 5-triphosphate …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2.

F Saccà, G Puorro, A Brunetti, G Capasso… - Journal of …, 2015 - search.ebscohost.com
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca efflux from the inositol-1, 4, 5-triphosphate …

[HTML][HTML] A randomized controlled pilot trial of lithium in spinocerebellar ataxia type two (932 views)

F Saccà, G Puorro, A Brunetti, G Capasso… - J Neurol (ISSN: 0340 …, 2015 - ibb.cnr.it
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is able to
stimulate autophagy, and to reduce Ca+ efflux from the inositol-1, 4, 5-triphosphate receptor …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti, G Capasso… - JOURNAL OF …, 2015 - iris.unicampania.it
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca2+ efflux from the inositol-1, 4, 5-triphosphate …

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Saccà, G Puorro, A Brunetti, G Capasso, A Cervo… - Journal of …, 2015 - infona.pl
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is able to
stimulate autophagy, and to reduce Ca2+ efflux from the inositol-1, 4, 5-triphosphate …

[PDF][PDF] A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2

F Sacca, G Puorro, A Brunetti, G Capasso, A Cervo… - 2014 - researchgate.net
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is
able to stimulate autophagy, and to reduce Ca2? efflux from the inositol-1, 4, 5-triphosphate …